Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-088708
Filing Date
2016-01-05
Accepted
2016-01-05 16:35:14
Documents
1
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3339
  Complete submission text file 0001209191-16-088708.txt   4833
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 646-214-0700
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Mailing Address 21 PENNIMAN RD BROOKLINE MA 02445-4122
Business Address
BELBEL CAESAR J (Reporting) CIK: 0001109753 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 161322755